R. ten Cate

4.2k total citations
81 papers, 2.5k citations indexed

About

R. ten Cate is a scholar working on Hematology, Speech and Hearing and Rheumatology. According to data from OpenAlex, R. ten Cate has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hematology, 36 papers in Speech and Hearing and 28 papers in Rheumatology. Recurrent topics in R. ten Cate's work include Autoimmune and Inflammatory Disorders Research (66 papers), Adolescent and Pediatric Healthcare (36 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). R. ten Cate is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (66 papers), Adolescent and Pediatric Healthcare (36 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). R. ten Cate collaborates with scholars based in Netherlands, United States and Germany. R. ten Cate's co-authors include Marion A. J. van Rossum, Lisette W. A. van Suijlekom‐Smit, Marinka Twilt, Nico Wulffraat, Esther P A H Hoppenreijs, Y. Koopman-Keemink, D. M. C. Brinkman, Wineke Armbrust, Lidia R. Arends and M.H. Otten and has published in prestigious journals such as JAMA, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

R. ten Cate

78 papers receiving 2.4k citations

Peers

R. ten Cate
Sarah Ringold United States
R. ten Cate
Citations per year, relative to R. ten Cate R. ten Cate (= 1×) peers Sarah Ringold

Countries citing papers authored by R. ten Cate

Since Specialization
Citations

This map shows the geographic impact of R. ten Cate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. ten Cate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. ten Cate more than expected).

Fields of papers citing papers by R. ten Cate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. ten Cate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. ten Cate. The network helps show where R. ten Cate may publish in the future.

Co-authorship network of co-authors of R. ten Cate

This figure shows the co-authorship network connecting the top 25 collaborators of R. ten Cate. A scholar is included among the top collaborators of R. ten Cate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. ten Cate. R. ten Cate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berg, J. Merlijn van den, Dieneke Schonenberg‐Meinema, Lisette W. A. van Suijlekom‐Smit, et al.. (2023). Patterns of clinical joint inflammation in juvenile idiopathic arthritis. RMD Open. 9(1). e002941–e002941. 5 indexed citations
2.
Müller, P, Cornelia F Allaart, D. M. C. Brinkman, et al.. (2018). Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?. BMC Medical Ethics. 19(1). 96–96. 7 indexed citations
3.
Müller, P, M. Kloppenburg, René E. M. Toes, et al.. (2017). Characterisation of Lipid Mediator Profile and Immune Cells in Synovial Fluid of Juvenile Idiopathic Arthritis. Arthritis & Rheumatism. 69. 1 indexed citations
4.
Müller, P, Dieneke Schonenberg‐Meinema, Y. Koopman-Keemink, et al.. (2017). Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis : First Results of Clinical Outcome after 24 Months. Data Archiving and Networked Services (DANS). 69.
5.
Anink, Janneke, Lisette W. A. van Suijlekom‐Smit, M.H. Otten, et al.. (2015). MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. Arthritis Research & Therapy. 17(1). 200–200. 58 indexed citations
7.
Müller, P, Andries E. Budding, C.F. Allaart, et al.. (2013). Intestinal Microbiome In Polyarticular Juvenile Idiopathic Arthritis : A PILOT Study. Data Archiving and Networked Services (DANS). 65. 2 indexed citations
8.
Mannurita, Sara Ciullini, Marina Vignoli, Lucia Bianchi, et al.. (2013). CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort. European Journal of Human Genetics. 22(2). 197–201. 28 indexed citations
9.
Allaart, Cornelia F, et al.. (2012). Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?. Data Archiving and Networked Services (DANS). 1 indexed citations
10.
Holzinger, Dirk, Michael Frosch, Femke H. M. Prince, et al.. (2012). The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 71(6). 974–980. 117 indexed citations
11.
Janssen, Carl, Carlos D. Rosé, Gert De Hertogh, et al.. (2012). Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2–related disorders Blau syndrome and Crohn disease. Journal of Allergy and Clinical Immunology. 129(4). 1076–1084. 50 indexed citations
12.
Prince, François, Marinka Twilt, Marion A. J. van Rossum, et al.. (2011). An analysis of the costs and treatment success of etanercept in Juvenile Idiopathic Arthritis. Clinical and Experimental Rheumatology. 29(2). 443–443. 1 indexed citations
13.
Otten, M.H., Femke H. M. Prince, Marinka Twilt, et al.. (2011). Tumor Necrosis Factor-blocking Agents for Children with Enthesitis-related Arthritis — Data from the Dutch Arthritis and Biologicals in Children Register, 1999–2010. The Journal of Rheumatology. 38(10). 2258–2263. 54 indexed citations
14.
Otten, M.H., François Prince, R. ten Cate, et al.. (2010). Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?. Annals of the Rheumatic Diseases. 70(2). 337–340. 16 indexed citations
15.
Kurreeman, Fina, Gerrie Stoeken‐Rijsbergen, Marion A. J. van Rossum, et al.. (2009). Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis & Rheumatism. 60(3). 901–904. 35 indexed citations
16.
Wessels, Judith A.M., D. M. C. Brinkman, Lisette W. A. van Suijlekom‐Smit, et al.. (2008). Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Care & Research. 61(1). 46–51. 100 indexed citations
17.
Cimaz, Rolando, Carlos D. Rosé, Jiřina Bartůňková, et al.. (2003). Primary Sjögren syndrome in the paediatric age: a multicentre survey. European Journal of Pediatrics. 162(10). 661–665. 108 indexed citations
18.
Wulffraat, Nico, Alina Ferster, R. ten Cate, et al.. (2003). Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplantation. 32(S1). S61–S64. 36 indexed citations
19.
Cate, R. ten, D. M. C. Brinkman, Arjan C. Lankester, et al.. (2002). Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis. European Journal of Pediatrics. 161(12). 685–686. 15 indexed citations
20.
Rossum, Marion A. J. van, T. Fiselier, Marcel J. A. M. Franssen, et al.. (1998). Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study. Arthritis & Rheumatism. 41(5). 808–816. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026